It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2004.
2004 | Navi Mumbai, Maharashtra, India | ActiveSiraigo Pharma Private Limited, a active private limited company, was established on 26 May 2004 in Navi Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24230MH2004PTC146558. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.78 M.
It upholds a active non-compliant status. Its leadership includes Balvinder Kaur (Director), Naresh Kumar (Director). Past directors included Om Prakash Gupta, Radhey Shyam Mittal, Ankit Mittal. It holds ₹6.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block No.13Sector-17 Kopar Khairane, Navi Mumbai, Maharashtra, 400709.
U24230MH2004PTC146558
146558
26 May 2004
₹1.00 M
₹0.78 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Siraigo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balvinder Kaur | Director | 05 Jul 2017 | Current |
| Naresh Kumar | Director | 05 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2016 | Past |
| Pramod Abcsdd | Director | 01 Mar 2016 | Past |
| Pramod Abcsdd | Director | 01 Mar 2016 | Past |
| Pramod Abcsdd | Director | 02 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Siraigo Pharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 433.03% increase. The company also saw a substantial fall in profitability, with a 4255.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Siraigo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2017 | State Bank Of India | ₹6.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Siraigo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Siraigo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siraigo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Siraigo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Siraigo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Balvinder Kaur was appointed as a Director was appointed as a Director on 05 Jul 2017 & has been associated with this company since 8 years 5 months . was recorded as a recent event.
The activity Naresh Kumar was appointed as a Director was appointed as a Director on 05 Jul 2017 & has been associated with this company since 8 years 5 months . was completed.
The activity A charge with State Bank Of India amounted to Rs. 6.00 M with Charge ID 100096836 was registered on 25 Apr 2017. was completed.
The activity Siraigo Pharma Private Limited was registered on 26 May 2004 with Roc Mumbai & aged 21 years 6 months as per MCA records. was completed.
The CIN of Siraigo Pharma Private Limited is U24230MH2004PTC146558.
Siraigo Pharma Private Limited is headquartered at Block No.13Sector-17 Kopar Khairane, Navi Mumbai, Maharashtra, 400709.
Siraigo Pharma Private Limited was incorporated on 26 May 2004.
The current directors of Siraigo Pharma Private Limited are
The primary industry of Siraigo Pharma Private Limited is Pharma.
Siraigo Pharma Private Limited is unlisted.
The authorized capital of Siraigo Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.78 M.
The compliance status of Siraigo Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX